A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
暂无分享,去创建一个
Bernhards Ogutu | B. Ogutu | S. Sirima | K. Hamed | A. Gansané | Alfred B Tiono | Alphonse Ouédraogo | Sam Coulibaly | Amidou Diarra | Sodiomon B Sirima | A. Tiono | A. Diarra | Kamal Hamed | Amitava Mukhopadhyay | Adama Gansané | Gregory O’Neil | A. Ouédraogo | A. Mukhopadhyay | S. Coulibaly | Gregory O’Neil
[1] Z. Premji,et al. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? , 2010, Malaria Journal.
[2] Teun Bousema,et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control , 2012, Nature Communications.
[3] V. Louis,et al. Moving towards universal coverage with malaria control interventions: achievements and challenges in rural Burkina Faso. , 2013, The International journal of health planning and management.
[4] C. Lengeler,et al. Insecticide-treated bed nets and curtains for preventing malaria. , 2004, The Cochrane database of systematic reviews.
[5] K. Marsh,et al. What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity , 2009, Malaria Journal.
[6] S. Cousens,et al. Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial , 2011, PloS one.
[7] Teun Bousema,et al. Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.
[8] Bernhards Ogutu,et al. Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis , 2011, Malaria Journal.
[9] O. Gaye,et al. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] André Garcia,et al. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants , 2008, Malaria Journal.
[11] K. Hamed,et al. Transitioning from malaria control to elimination: the vital role of ACTs. , 2013, Trends in parasitology.
[12] J. Aponte,et al. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings , 2009, Malaria Journal.
[13] S. Sirima,et al. The effects of a pre‐season treatment with effective antimalarials on subsequent malaria morbidity in under five‐year‐old children living in high and seasonal malaria transmission area of Burkina Faso , 2010, Tropical medicine & international health : TM & IH.
[14] N. Nanda,et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria , 2012, Malaria Journal.
[15] Z. Premji,et al. Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis , 2011, The American journal of tropical medicine and hygiene.
[16] S. Lindsay,et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[17] Purnomo,et al. Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis. , 1997, American Journal of Tropical Medicine and Hygiene.
[18] Aniset Kamanga,et al. A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia , 2010, Malaria Journal.
[19] Weltgesundheitsorganisation. World malaria report , 2005 .
[20] T. Déirdre Hollingsworth,et al. The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria , 2011, PloS one.
[21] P. Milligan,et al. Gametocytaemia after Drug Treatment of Asymptomatic Plasmodium falciparum , 2006, PLoS clinical trials.
[22] T. Bousema,et al. Adjusting for heterogeneity of malaria transmission in longitudinal studies. , 2011, The Journal of infectious diseases.
[23] Svensson,et al. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. , 1999, The Journal of infectious diseases.